BAD and cancer: In order to assess the inhibitory activities of YPC-21440 and YPC-21817 against Pim kinases in cells, we determined the phosphorylation levels of substrates of Pim kinases, Bad, 4EBP, and p21, in cancer cell lines treated with these compounds (Figure 3B).